Celeste Baccarin Marangoni

Mrs. Celeste Baccarin Marangoni

ABS - Atlantic Business School, Vila Nova de Gaia, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Lara LopesLara Lopes
Lara Lopes
Jorge Magalhães RodriguesJorge Magalhães Rodrigues
Jorge Magalhães Rodrigues
CMCeleste Baccarin Marangoni
Celeste Baccarin Marangoni
KOKevin Oliveira
Kevin Oliveira
MAManuela Abreu
Manuela Abreu
Jorge Pereira MachadoJorge Pereira Machado
Jorge Pereira Machado
Autism spectrum disorder (ASD) is the most common neurodevelopmental disorder with a huge prevalence increasing every year (1/44 children). Still diagnosed as a mental disorder, the last 10 years of research found possible causes, risks, genetics, environmental triggers, epigenetics, metabolic, immunological, and neurophysiological unbalances as relevant aetiology. Umbrella methodology is the highest level of scientific evidence, designed to support clinical and political decisions. A literature search for autism aetiology, pathophysiology, or causes, conducted in the last 10 years, at PubMed, Embase, Cochrane, Scopus, and the Web of Science, resulted in six umbrella reviews. Nevertheless, only one quantitative analysis reported risk factors and biomarkers but excluded genetics, experiments on animal models, and post-mortem studies. We grouped ASD’s multi-factorial causes and risks into five etiological categories: genetic, epigenetic, organic, psychogenic, and environmental. Findings suggest that autism might be evaluated as a systemic disorder instead of only through the lens of mental and behavioural. The overview implications of included studies will be qualitatively analysed under ROBIS and GRADE tools. This umbrella review can provide a rational basis for a new urgent health policy to develop better and adequate integrated care services for ASD. The methodological protocol has the register CRD42022348586 at PROSPERO.